Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,517
Closed -$113K 1382
2025
Q4
$113K Buy
+1,517
New +$111K ﹤0.01% 793
2024
Q3
Sell
-3,249
Closed -$241K 533
2024
Q2
$241K Buy
+3,249
New +$244K 0.01% 494
2024
Q1
Sell
-3,861
Closed -$289K 612
2023
Q4
$289K Buy
+3,861
New +$269K 0.01% 522

Other funds holding HOLX

SageView Advisory Group's HOLX Position: Q1 2026 in Review

SageView Advisory Group sold out of Hologic (HOLX) in Q1 2026, closing a stake of 1,517 shares — an estimated $113K sold.

SageView Advisory Group first reported a position in HOLX in Q4 2023 and held it in 3 quarters. The position peaked at $289K in Q4 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • SageView Advisory Group reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • SageView Advisory Group sold 1,517 Hologic shares in Q1 2026, an estimated $113K.
  • SageView Advisory Group first reported a position in Hologic in Q4 2023 and held it in 3 quarters.
  • SageView Advisory Group's Hologic position peaked at $289K in Q4 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.